228 Interim Results of an Open-label Extension Study of Antolimab, an Anti-siglec-8 Antibody, for the Treatment of Patients With Eosinophilic Gastritis And/or Eosinophilic Enteritis
Year: 2020
Type: article
Source: Gastroenterology
Authors: Kathryn A. Peterson, Joseph A. Murray, Gary W. Falk, Nirmala Gonsalves, Mirna Chehade, John Leung, Robert M. Genta, Marc E. Rothenberg, Paneez Khoury, Adam C. Bledsoe, Sandy R. Durrani, Camilla Shaw, Henrik S. Rasmussen, Bhupinder Singh, Alan T. Chang, Amol P. Kamboj, Ikuo Hirano, Evan S. Dellon
Language: English
Topic: Eosinophilic Esophagitis
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3026214312
